<ѻýҕl>Blood Viscosity Enters the Equation in COVID Mortalityѻýҕl> Its association with death may be unrelated to inflammation Jul 18, 2022
<ѻýҕl>How Realistic Is Radical Prostatectomy Without Prior Biopsy?ѻýҕl> German case series suggests it may be feasible Jul 12, 2022
<ѻýҕl>Bone Marrow Biopsy Value Limited in Follicular Lymphoma Response Assessmentѻýҕl> Information useful in fewer than 1% of patients with untreated disease Jul 10, 2022
<ѻýҕl>'Don't Let Me Die in Pain,' My Patient Pleadedѻýҕl> We must better manage the suffering of patients with a history of substance use disorder Jul 09, 2022
<ѻýҕl>Zanubrutinib Wins in First-Line CLL for Older Patientsѻýҕl> The BTK inhibitor proves superior to bendamustine-rituximab in phase III trial Jul 08, 2022
<ѻýҕl>Acetaminophen Blunts Antitumor Activity of Immunotherapyѻýҕl> Lower response rates, worse survival seen in patients with detectable levels of the antipyretic Jul 07, 2022
<ѻýҕl>Missed Opportunities for Advance Care Planning After GI Surgeryѻýҕl> Multiple admissions typical leading up to urgent procedures followed by discharge to hospice Jul 07, 2022
<ѻýҕl>CEND-1 Offers Hope in Advanced Pancreatic Cancerѻýҕl> Phase I study showed good safety profile, no dose-limiting toxicities, and encouraging activity Jul 06, 2022
<ѻýҕl>Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumorsѻýҕl> However, trial comparing robotic and open surgery was stopped early due to low enrollment Jul 06, 2022
<ѻýҕl>FDA Warns of Increased Mortality Risk With Duvelisibѻýҕl> Drug approved for adults with CLL/SLL Jul 01, 2022
<ѻýҕl>Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screeningѻýҕl> Hepatocellular carcinoma risk persisted after direct-acting antivirals Jun 30, 2022
<ѻýҕl>Therapeutic Use of Cannabis: Risks, Benefits, Legalityѻýҕl> Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
<ѻýҕl>Art, Drama, and a Terminal Illnessѻýҕl> How Ellen Dunphy turned her cancer diagnosis into art Jun 28, 2022 podcast
<ѻýҕl>Over $20 Million Paid to a Select Group of Top U.S. Oncologistsѻýҕl> "The findings identify a risk for perceived and real conflict of interest," study author says Jun 27, 2022
<ѻýҕl>Kidney Failure May Drive COVID Deaths in People With Sickle Cell Traitѻýҕl> COVID-19 severity strongly linked with sickle cell anemia as well Jun 27, 2022
<ѻýҕl>Toby Keith's Gastric Cancerѻýҕl> The country star announced he's been treated for the last 6 months Jun 23, 2022
<ѻýҕl>Adding Opdivo in First-Line Shows Promise in HER2+ Esophagogastric Cancerѻýҕl> Improved OS compared with historical standard or chemo-free approach Jun 23, 2022
<ѻýҕl>Do Therapy-Related Hot Flashes in Breast Cancer Signal Worse Outcomes?ѻýҕl> Swedish study finds reduced DFS in women who used drugs for hot flashes Jun 22, 2022
<ѻýҕl>Brentuximab Vedotin Boosts Survival in Untreated Hodgkin Lymphomaѻýҕl> ECHELON-1 analysis showed 41% mortality risk reduction versus standard treatment Jun 21, 2022
<ѻýҕl>Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancerѻýҕl> Decision on rucaparib follows negative OS signal and "discussions" with FDA Jun 17, 2022
<ѻýҕl>MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancerѻýҕl> QOL outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said Jun 17, 2022
<ѻýҕl>Xtandi During AS Reduced Progression Risk in Early Prostate Cancerѻýҕl> Risk of disease progression cut by 46% versus those on active surveillance alone Jun 16, 2022
<ѻýҕl>Early Anal Lesion Treatment Cuts Cancer Risk in People With HIVѻýҕl> ANCHOR data support screening and treatment for anal HSIL in those ages 35 and up Jun 15, 2022
<ѻýҕl>Harms of Cancer Blood Tests? FTC Healthcare Crackdown: More Smoke Than Fire?ѻýҕl> This past week in healthcare investigations Jun 15, 2022
<ѻýҕl>Lorlatinib Reduces CNS Progression in ALK-Positive NSCLCѻýҕl> Post-hoc analysis of CROWN trial does find more central nervous system toxicity, however Jun 14, 2022
<ѻýҕl>Does Ditching Cost-Sharing Boost Follow-Up Colonoscopy?ѻýҕl> States saw differing results with policies eliminating costs after a positive noninvasive test Jun 14, 2022
<ѻýҕl>Studies Reinforce Prognostic Role for Circulating Tumor Cells in Myelomaѻýҕl> At higher levels, different cutoffs show at least a doubling of PFS, OS hazard ratios Jun 13, 2022
<ѻýҕl>Diabetes Threatens Long-Term Survival in Metastatic Breast Cancerѻýҕl> 5-year survival rates were not affected, however Jun 13, 2022
<ѻýҕl>FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kidsѻýҕl> Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors Jun 10, 2022
<ѻýҕl>Something Fishy About Tuna and Melanoma Riskѻýҕl> Higher total fish intake linked with 22% higher risk of malignant tumors Jun 09, 2022
<ѻýҕl>P53 Antagonist Shows Early Activity in Advanced Liposarcomaѻýҕl> ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
<ѻýҕl>Intensified Regimen for Metastatic CRC Fails to Improve Outcomesѻýҕl> Combination of modified FOLFOXIRI/panitumumab also caused greater toxicity, study showed Jun 08, 2022
<ѻýҕl>A Better Way to Irradiate Lethal CNS Metastases?ѻýҕl> Randomized trial makes case for proton craniospinal irradiation for leptomeningeal spread Jun 08, 2022
<ѻýҕl>First-Line Anti-EGFR Extends OS in Left-Sided Colorectal Cancerѻýҕl> "A win for a highly selected group of patients," says ASCO expert Jun 07, 2022
<ѻýҕl>PARP Inhibitor Picks Up a Win in Frontline Maintenance for Ovarian Cancerѻýҕl> Median PFS more than doubled with rucaparib after response to platinum-based chemotherapy Jun 07, 2022
<ѻýҕl>Forego Radiotherapy for Women With Low-Risk Luminal A Breast Cancer?ѻýҕl> Study shows 5-year local recurrence rate of 2.3% with lumpectomy and endocrine therapy alone Jun 07, 2022
<ѻýҕl>She Found Out She Had Prostate Cancerѻýҕl> Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
<ѻýҕl>Targeted Combo Topples Chemo in Pediatric Glioma With BRAF Mutationsѻýҕl> ORR quadrupled, median PFS nearly tripled with dabrafenib plus trametinib in low-grade disease Jun 06, 2022
<ѻýҕl>Radiation Alone May Suffice for Some Nasopharyngeal Cancerѻýҕl> Chemotherapy adds little benefit in intermediate grade lesions Jun 06, 2022